BRUKER CORPORATION Equity Method Investment, Realized Gain (Loss) on Disposal
BRUKER CORPORATION (BRKR) reported Equity Method Investment, Realized Gain (Loss) on Disposal of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal · last filed 2025-03-03
- BRUKER CORPORATION equity method investment, realized gain (loss) on disposal for the quarter ending 2024-12-31 was $0.00.
- BRUKER CORPORATION equity method investment, realized gain (loss) on disposal for the quarter ending 2024-09-30 was $0.00.
- BRUKER CORPORATION equity method investment, realized gain (loss) on disposal for the quarter ending 2023-12-31 was $0.00.
- BRUKER CORPORATION equity method investment, realized gain (loss) on disposal for the quarter ending 2023-09-30 was $0.00.
- BRUKER CORPORATION equity method investment, realized gain (loss) on disposal for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- BRUKER CORPORATION equity method investment, realized gain (loss) on disposal for fiscal 2023 was $6.80M.
- BRUKER CORPORATION equity method investment, realized gain (loss) on disposal for fiscal 2022 was $0.00.
- BRUKER CORPORATION equity method investment, realized gain (loss) on disposal for fiscal 2021 was $0.00.
| Period end | Equity Method Investment, Realized Gain (Loss) on Disposal 3 month | Equity Method Investment, Realized Gain (Loss) on Disposal 6 month | Equity Method Investment, Realized Gain (Loss) on Disposal 9 month | Equity Method Investment, Realized Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-09 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $6.80M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $6.80M 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $6.80M 10-Q · filed 2024-08-09 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |